CORD-19:00a0ab182dc01b6c2e737dfae585f050dcf9a7a5 / 88270-88664 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T204","span":{"begin":0,"end":394},"obj":"Sentence"}],"text":"Testing of formulations previously approved by the Food and Drug Agency (FDA; USA) at the Small-molecule Inhibitor Leads Versus Emerging and neglected RNA viruses (SILVER) project described four existing compounds (chloroquine, chlorpromazine, loperamide and lopinavir) that inhibit MERS-CoV, SARS-CoV and HCoV-229E replication in cell culture (de Wilde et al., 2014; SILVER consortium, 2015) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T471","span":{"begin":0,"end":394},"obj":"Sentence"},{"id":"T36853","span":{"begin":0,"end":394},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Testing of formulations previously approved by the Food and Drug Agency (FDA; USA) at the Small-molecule Inhibitor Leads Versus Emerging and neglected RNA viruses (SILVER) project described four existing compounds (chloroquine, chlorpromazine, loperamide and lopinavir) that inhibit MERS-CoV, SARS-CoV and HCoV-229E replication in cell culture (de Wilde et al., 2014; SILVER consortium, 2015) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T337","span":{"begin":293,"end":301},"obj":"Disease"},{"id":"T338","span":{"begin":293,"end":297},"obj":"Disease"}],"attributes":[{"id":"A337","pred":"mondo_id","subj":"T337","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A338","pred":"mondo_id","subj":"T338","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Testing of formulations previously approved by the Food and Drug Agency (FDA; USA) at the Small-molecule Inhibitor Leads Versus Emerging and neglected RNA viruses (SILVER) project described four existing compounds (chloroquine, chlorpromazine, loperamide and lopinavir) that inhibit MERS-CoV, SARS-CoV and HCoV-229E replication in cell culture (de Wilde et al., 2014; SILVER consortium, 2015) ."}